This document is a patent application filed with the USPTO, not a regulatory rule or guidance. It describes methods and compositions utilizing specific plants (Dichrostachys glomerata or Cissus quadrangularis) to potentially reduce food intake, appetite, and other health markers such as GLP-1 levels, visceral fat, blood lipids, total cholesterol, and total glucose in mammals. The application was filed on September 26, 2024, under application number 18898575 and is designated for publication as US20260083809A1 on March 26, 2026.

As this is a patent application, it does not impose immediate compliance obligations on regulated entities. However, companies in the pharmaceutical, food manufacturing, or health and wellness sectors may wish to monitor the progress of this patent application and any subsequent granted patents. The claims within the patent, if granted, could impact the development and marketing of related products, potentially requiring licensing agreements or influencing product formulation strategies for those operating in related therapeutic areas.